Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI) (VR adult)

Albert Einstein College of Medicine

Status and phase: Withdrawn; Phase 2

Conditions: Pain

Treatments: Drug: Bupivacaine; Drug: Lidocaine Hydrochloride; Device: Oculus; Device: Google Cardboard

Study type: Interventional

Funder types: Other

Identifiers

NCT03787147

2018-9613

Details and patient eligibility

About

A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult requiring Spinal Injections
• Adult > 18years
• Adults with intact vision who can attend VR intervention

Exclusion criteria

• Anyone < 18 years
• Adults who are not attentive to VR secondary to poor concentration, poor cognition to external stimuli
• Adults who request moderate IV sedation
• Adults with photic-induced seizures

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 3 patient groups

Spinal Injection

Other group

Description:

Adults receiving Spinal Injection(SI) without Virtual Reality(VR).

Treatment:

Drug: Lidocaine Hydrochloride

Drug: Bupivacaine

Google Cardboard

Active Comparator group

Description:

Adults receiving SI while using Google Cardboard Virtual reality head mounted display powered by a iPod touch

Treatment:

Drug: Lidocaine Hydrochloride

Device: Google Cardboard

Drug: Bupivacaine

Oculus

Active Comparator group

Description:

Adults receiving SI while using VR with Oculus Rift.

Treatment:

Drug: Lidocaine Hydrochloride

Device: Oculus

Drug: Bupivacaine